Author:
Bystriakova M. A.,Koshkin S. A.,Gavrilyukov A. V.,Tolkunova E. N.
Reference44 articles.
1. Ambrosetti, D., Dufies, M., Dadone, B., Durand, M., Borchiellini, D., Amiel, J., Pouyssegur, J., Rioux-Leclercq, N., Pages, G., Burel-Vandenbos, F., and Mazure, N.M., The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma, PLoS One, 2018, vol. 13.
2. Asadi, M.H., Mowla, S.J., Fathi, F., Aleyasin, A., Asadzadeh, J., and Atlasi, Y., OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor, Int. J. Cancer, 2011, vol. 128, pp. 2645–2652.
3. Asadi, M.H., Khalifeh, K., and E, Mowla, S.J., OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells, J. Neurooncol., 2016, vol. 130, pp. 455–463.
4. Asadzadeh, J., Asadi, M.H., Shakhssalim, N., Rafiee, M.R., Kalhor, H.R., Tavallaei, M., and Mowla, S.J., A plausible anti-apoptotic role of up-regulated OCT4B1 in bladder tumors, Urol. J., 2012, vol. 9, pp. 574–580.
5. Atlasi, Y., Mowla, S.J., Ziaee, S.A., Gokhale, P.J., and Andrews, P.W., OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells, Stem Cells, 2008, vol. 26, pp. 3068–3074.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献